ФОКАЛЬНЫЕ ДИСТОНИИ: НЕМОТОРНЫЕ СИМПТОМЫ И КОМОРБИДНОСТЬ
Аннотация
Дистония является распространенным экстрапирамидным заболеванием. Для нее характерны как моторные, так и немоторные проявления, к которым относятся боль, сенсорные нарушения, избыточная двигательная активность. Обсуждается вклад тревожных и депрессивных расстройств, нарушений сна в течение фокальной дистонии. Нередко именно немоторные проявления являются начальными симптомами дистонии. В ряде случаев немоторные проявления можно выделить в самостоятельные заболевания, которые сопутствуют дистоническому гиперкинезу и способствуют ухудшению качества жизни таких больных. Лечение немоторных симптомов позволит повысить эффективность терапии дистонии, а также повлиять на течение заболевания.
Об авторе
В. А. Толмачёва
Первый Московский государственный медицинский университет им. И.М. Сеченова
Россия
Россия
Кандидат медицинских наук
Список литературы
1. Hertenstein E, Tang NK, Bernstein CJ, Nissen C, Underwood MR, Sandhu HK. Sleep in patients with primary dystonia: a systematic review on the state of research and perspectives. Sleep Med Rev, 2016 Apr, 26: 95-107.
2. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov. Disord., 2012 Dec, 27(14): 1789-96.
3. Albanese A, Asmus F, Bhatia K et al. EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology, 2011, 18: 5-18.
4. Голубев В.Л., 1991; Орлова О.Р. Фокальные дистонии: клиника, патогенез, лечение с использованием токсина ботулизма. Дис. ... докт. мед. наук. М., 2000. 300 c.
5. Давиденков С.Н. Клинические лекции по нервным болезням. Выпуск второй. Медгиз. Ленинградское отделение. 1956. С. 56.
6. Stefurak T, Mikulis D, Mayberg H, Lang AE, Hevenor S, Pahapill P et al. Deep brain stimulation for Parkinson’s disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord, 2003, 18: 1508-16.
7. Gundel H, Wolf A, Xidara V, Busch R, Ladwig KH, Jacobi F, et al. High psychiatric comorbidity in spasmodic torticollis: a controlled study. J Nerv Ment Dis, 2003, 191: 465-73.
8. Lencer R, Steinlechner S, Stahlberg J, Rehling H, Orth M, Baeumer T et al. Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry, 2009, 80: 1176-9.
9. Voon V, Butler TR, Ekanayake V, Gallea C, Ameli R, Murphy DL, et al. Psychiatric symptoms associated with focal hand dystonia. Mov Disord, 2010, 25: 2249-52.
10. Skogseid IM, Malt UF, Roislien J, Kerty E. Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. Eur J Neurol, 2007, 14: 1129-37.
11. Mueller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord, 2008, 23: 131-4.
12. Bihari K, Hill JL, Murphy DL. Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollis. Psychiatry Res, 1992a, 42: 267-72.
13. Broocks A, Thiel A, Angerstein D, Dressler D. Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry, 1998, 155: 555-7.
14. Wenzel T, Schnider P, Wimmer A, Steinhoff N, Moraru E, Auff E. Psychiatric comorbidity in patients with spasmodic torticollis. J Psychosom Res, 1998, 44: 687-90.
15. Cavallaro R, Galardi G, Cavallini MC, Henin M, Amodio S, Bellodi L, et al. Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry, 2002, 52: 356-61.
16. Moraru E, Schnider P, Wimmer A, Wenzel T, Birner P, Griengl H, et al. Relation between depression and anxiety in dystonic patients: implications for clinical management. Depress Anxiety, 2002, 16: 100-3.
17. Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C, et al. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord, 2010, 25: 459-65.
18. Heiman GA, Ottman R, Saunders-Pullman RJ, Ozelius LJ, Risch NJ, Bressman SB. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology, 2004, 63: 631-7.
19. Allam N, Frank JE, Pereira C, Tomaz C. Sustained attention in cranial dystonia patients treated with botulinum toxin. Acta Neurol Scand, 2007, 116: 196-200.
20. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med, 2005, 352: 459-67.
21. Pillon B, Ardouin C, Dujardin K, Vittini P, Pelissolo A, Cottencin O et al. Preservation of cognitive function in dystonia treated by pallidal stimulation. Neurology, 2006, 66: 1556-8.
22. Anca MH, Zaccai TF, Badarna S, Lozano AM, Lang AE, Giladi N. Natural history of Oppenheim’s dystonia (DYT1) in Israel. J Child Neurol, 2003, 18: 325-30.
23. Silvestri R, De Domenico P, Di Rosa AE, Bramanti P, Serra S, Di Perri R. The effect of nocturnal physiological sleep on various movement disorders. Mov Disord, 1990, 5: 8-14.
24. Sforza E, Montagna P, Defazio G, Lugaresi E. Sleep and cranial dystonia. Electroencephalogr Clin Neurophysiol, 1991, 79: 166-9.
25. Avanzino L, Martino D, Marchese R, Aniello MS, Minafra B, Superbo M, et al. Quality of sleep in primary focal dystonia: a case-control study. Eur J Neurol, 2010, 17: 576-81.
26. Paus S, Gross J, Moll-Muller M, Hentschel F, Spottke A, Wabbels B, et al. Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. J Neurol, 2011, 258: 1835-40.
27. Trotti LM, Esper CD, Feustel PJ, Bliwise DL, Factor SA. Excessive daytime sleepiness in cervical dystonia. Parkinsonism Relat Disord, 2009, 15: 784-6.
28. Yang J, Shao N, Song W et al. Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Brain Behav, 2017, 7.
29. Dauvilliers Y, Tafti M. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation. Sleep Med Rev, 2014 Aug, 22: 47-53.
30. Eichenseer SR, Stebbins GT, Comella CL. Beyond a motor disoder: a prospective evaluation of sleep quality in cervical dystonia. Park Relat Disord, 2014, 20: 405-8.
31. Buscemi N, Vandermeer B, Friesen C et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med, 2007, 22: 1335-50.
32. Kales A, Kales JD. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. J Clin Psychopharmacol, 1983, 3: 140-50.
33. Wilson SJ, Nutt DJ. SSRIs and sleep in man. In: Sleep and sleep disorders. New York City: Springer, 2006: 269-73.
34. Sforza E, Montagna P, Defazio G, Lugaresi E. Sleep and cranial dystonia. Electroencephalogr Clin Neuophysiol, 1991, 79: 166-9.
35. Lobbezoo F, Thu Thon M, Remillard G, Montplaisir JY, Lavigne GJ. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci, 1996, 23: 285-90.
36. Feige B, Voderholzer U, Riemann D, Hohagen F, Berger M. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-halflife hypnotics in healthy subjects. Clin Neurophysiol, 1999, 110: 1965-74.
37. Werle RW, Takeda SYM, Zonta MB, Guimaraes ATB, Teive HAG. The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia. Arq Neuropsiquiatr, 2014, 72: 405-10.
38. Ghika J, Regli F, Growdon JH. Sensory symptoms in cranial dystonia: a potential role in the etiology? J Neurol Sci, 1993, 116: 142-7.
39. Martino D, Defazio G, Alessio G, Abbruzzese G, Girlanda P, Tinazzi M, et al. Relationship between eye symptoms and blepharospasm: a multicenter case-control study. Mov Disord, 2005, 20: 1564-70.
40. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain, 2007, 130(Pt 5): 1183-93.
41. Yoshida K, Kaji R, Kubori T, Kohara N, Iizuka T, Kimura J. Muscle afferent block for the treatment of oromandibular dystonia. Mov Disord, 1998, 13: 699-705.
42. Wissel J, Muller J, Ebersbach G, Poewe W. Trick maneuvers in cervical dystonia: investigation of movementand touch-related changes in polymyographic activity. Mov Disord, 1999, 14: 994-9.
43. Masuhr F, Wissel J, Muller J, Scholz U, Poewe W. Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor. Mov Disord, 2000, 15: 960-4.
44. Naumann M, Magyar-Lehmann S, Reiners K, Erbguth F, Leenders KL. Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming. Ann Neurol, 2000, 47: 322-8.
45. Muller J, Wissel J, Masuhr F, Ebersbach G, Wenning GK, Poewe W. Clinical characteristics of the geste antagoniste in cervical dystonia. J Neurol, 2001, 248: 478-82.
46. Lo SE, Gelb M, Frucht SJ. Geste antagonistes in idiopathic lower cranial dystonia. Mov Disord, 2007, 22: 1012-7.
47. Schramm A, Classen J, Reiners K, Naumann M. Characteristics of sensory trick-like manoeuvres in jaw-opening dystonia. Mov Disord, 2007, 22: 430-3.
48. Tang JK, Mahant N, Cunic D, Chen R, Moro E, Lang AE, et al. Changes in cortical and pallidal oscillatory activity during the execution of a sensory trick in patients with cervical dystonia. Exp Neurol, 2007, 204: 845-8.
49. Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Tepavcevic DK, et al. Quality of life in patients with focal dystonia. Clin Neurol Neurosurg, 2009, 111: 161-4.
50. Tepavcevic DK, Svetel M, Pekmezovic T, Petrovic I, Kostic VS. Craniocervical Dystonia Questionnaire (CDQ-24): validation and cross-cultural adaptation in Serbian patients. Coll Antropol, 2009, 33: 1185-9.
51. Bezerra ME, Rocha-Filho PA.Headache. Headache Attributed to Craniocervical Dystonia. A Little Known Headache, 2017 Feb, 57(2): 336-343.
52. Gudex CM, Hawthorne MR, Butler AG, Duffey P. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord, 1998, 13: 941-6.
53. Lindeboom R, Brans JW, Aramideh M, Speelman HD, De Haan RJ. Treatment of cervical dystonia: a comparison of measures for outcome assessment. Mov Disord, 1998, 13: 706-12.
54. Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry, 2002, 72: 608-14.
55. Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol, 2002, 249: 842-6.
56. Cano SJ, Hobart JC, Edwards M, Fitzpatrick R, Bhatia K, Thompson AJ, et al. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology, 2006, 67: 2230-2.
57. Page D, Butler A, Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord, 2007, 22: 341-7.
58. Zhang SS, Fang DF, Hu XH, Burgunder JM, Chen XP, Zhang YW, et al. Clinical feature and DYT1 mutation screening in primary dystonia patients from South-West China. Eur J Neurol, 2010, 17: 846-51.
59. Soeder A, Kluger BM, Okun MS, Garvan CW, Soeder T, Jacobson CE et al. Mood and energy determinants of quality of life in dystonia. J Neurol, 2009, 256: 996-1001.
60. Wagle Shukla A, Brown R, Heese K, Jones J, Rodriguez RL, Malaty IM, Okun MS, Kluger BM. High rates of fatigue and sleep disturbances in dystonia. Int J Neurosci, 2016 Oct, 126(10): 928-35.
61. Perozzo P, Salatino A, Cerrato P, Ricci R. Sexual well-being in patients with blepharospasm, spasmodic torticollis, and hemifacial spasm: a pilot study. Front. Psychol. 7: 1492.
62. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother, 1998, 32: 692-8.
63. Beck JS. Cognitive Behavior Therapy: Basics and Beyond. 2nd ed. New York: The Guilford Press, 2011.
64. Клиническое руководство по психическим расстройствам. Под ред. Д. Барлоу, 3-е изд. СПб.: Питер, 2008.
Для цитирования:
Толмачёва В.А. ФОКАЛЬНЫЕ ДИСТОНИИ: НЕМОТОРНЫЕ СИМПТОМЫ И КОМОРБИДНОСТЬ. Медицинский Совет. 2017;(10):81-86. https://doi.org/10.21518/2079-701X-2017-10-81-86
For citation:
Tolmachyova V.A. FOCAL DYSTONIAS: NON-MOTOR SYMPTOMS AND COMORBIDITIES. Meditsinskiy sovet = Medical Council. 2017;(10):81-86. (In Russ.) https://doi.org/10.21518/2079-701X-2017-10-81-86
Просмотров: 227
Послать статью по эл. почте 